Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil's soaring dengue rates trigger diagnostics boost

This article was originally published in Clinica

Executive Summary

In the face of Brazil’s soaring rates of dengue this year, the health ministry is pouring an extra R$4.1 million (US$2.1 million) into three of the worst-hit states to spend specifically on diagnostics and treatment supplies. Goi�s, Mato Grosso do Sul and Minas Gerais will receive the funding, which comes on top of a R$173.3 million national dengue budget in 2013 (up from R$93 million on 2012), approved for local dengue programmes, including non-healthcare actions. Federal healthcare authorities recorded 635,000 confirmed cases between 1 January and 23 March, compared with 167,000 during the same period in 2012. This year’s figures include almost 1,300 acute cases and 110 deaths. And the figures are set to escalate far further, new data suggest: Minas Gerais, which is the worst affected state, officially accounted for 133,000 of the national total at 23 March, but by early April, the state authorities were reporting 165,000.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT100242

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel